The company has made significant progress in the past 6 months, including developing a unique array of devices, assembling a world-class Scientific Advisory Board, amassing 13 patents, and completing pre-clinical studies. Viseon's devices use visualization and illumination technologies to improve procedural and clinical outcomes, reduce costs, and enhance safety. The company aims to bring innovative technology to MISS, disrupting antiquated modalities and advancing patient outcomes and safety.